Small per-case gains
compound fast.
At 300 EP cases per year, a $500 improvement per case is $150,000 of EBITDA. A $1,000 improvement is $300,000. These aren't projections — they're arithmetic. Purchasing leverage is the most direct lever available to independent ASCs in a fixed-reimbursement environment.
In a fixed-reimbursement world,
control what you can.
Physician-controlled aggregation
is no longer optional.
Hospitals aggregated first. Private equity aggregated next. Vendors consolidated globally. Yet many independent ASCs are still negotiating one by one. That's a mismatch in scale — and it's a structural disadvantage.
The transition
is happening
right now.
If you want access without damaging economics, you need leverage during the transition — not after. Early adopters shape referral networks.
Not a buying club.
An economic coordination layer.
We negotiate around total economic structure — pricing, capital, roadmap, and data — not just disposable SKU cost.
Scale with transparency
creates durability.
If a GPO cannot clearly articulate its compliance structure, that's not a small issue — that's governance weakness. ACCESS is built on explicit, auditable, physician-protective governance from day one.
Medtronic PFA access —
already demonstrated.
ACCESS GPO has already demonstrated physician-led negotiating power through a successful Medtronic PFA access arrangement for independent ASCs. This is not a concept — it's a live contract.
Start saving on day one.
No fees. No commitments.
Membership in ACCESS GPO is free for any physician-owned or physician-led EP ASC. Apply and get immediate access to the Medtronic contract and all future vendor agreements as they're added.